📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV. (2021)

First Author: Paton NI

Attributed to: Pathogen Genomics, Phenotype and Immunity (PGPI) & Basic Sciences Programme funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2101609

PubMed Identifier: 34289276

Publication URI: http://europepmc.org/abstract/MED/34289276

Type: Journal Article/Review

Volume: 385

Parent Publication: The New England journal of medicine

Issue: 4

ISSN: 0028-4793